This one really fascinates me as it really looks like this a 1st line treatment - not 4th or more like some other trials so one would hope the patient population has an immune system able to utilise the PD1-vaxx effectively.
What I am most curious about is the research that has lead to this trial being established- there’s some background here that I think would make for good reading.
Fully understand a readout for this is going to take a while, and as we have seen elsewhere, it takes time to demonstrate an increase in OS. But I’m sure there’s more to the story here I’d like to understand.
cheers,
YS
Ann: New PD1-Vaxx Phase 2 CRC Cancer Trial to Open in UK and AUS, page-30
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.001(1.79%) |
Mkt cap ! $418.9M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.4¢ | $461.9K | 8.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1082545 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 603058 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |